Proactive Investors - Run By Investors For Investors

Curis expecting pivotal 2019 with data on 3 potential products to be released

Curis Inc (NASDAQ:CRIS) CEO Jim Dentzer sat down with Christine Corrado from Proactive Investors at the 11th Annual Biotech Showcase in San Francisco. The Lexington, Massachusetts biotechnology company focused on the development and commercialization of innovative therapeutics for the treatment of cancer currently has three drug candidates in development.

View full CRIS profile View Profile

Curis Inc. Timeline

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use